Virax Biolabs

At Virax Biolabs, we are looking to understand the role of the adaptive immune system in symptoms associated with post-viral syndromes such as Long-Covid, whose etiologies are poorly understood. To that end, our ViraxImmune™ platform is aimed at developing a portfolio of T-cell diagnostics focusing on early detection of T-cell exhaustion to enable early treatment interventions. Watch our new #video here to learn more. #vrax #viraxbiolabs #viraximmune #tcells #ivds #longcovid

Dr. Nigel McCracken, COO, recently spoke to Tori Whitacre Martonicz of Infection Control Today® about our ViraxImmune T cell profiling platform and our critical research collaboration with The University of Manchester. He discusses the principles of our assay and how the findings from our collaborative study could pave the way for a novel diagnostic for Long COVID and other similar post-acute infection syndromes. You can watch the interview in full here: https://lnkd.in/gr-JzpxH #vrax #viraxbiolabs #viraximmune #longcovid #immunology #tcell

We're #hiring a new Quality Assurance Manager in Motherwell, Scotland. Apply today or share this post with your network.

At IDWeek 2024, Dr. Nigel McCracken, COO, spoke with Contagion_Live's Sophia Abene about both the potential and the important role of our T-Cell diagnostics in early identification of T-Cell dysfunction from Post-Acute Infection Syndromes (PAISs) such as Long COVID, chronic fatigue syndrome, and Lyme disease. Read his insights in full here: https://lnkd.in/eQF6Mbes #vrax #viraxbiolabs #viraximmune #IDWeek2024

Today, we're pleased to announce that we've signed a distribution agreement with Europa Biosite to commercialize our ImmuneSelect Research-Use Only range in the UK & Ireland. This will enable us to make this portfolio more accessible to researchers and pharmaceutical companies in the Isles than ever before. Read our press release in full here: https://lnkd.in/g7AzeYYH #vrax #viraxbiolabs #ViraxImmune #ImmuneSelect

Arrived at IDWeek 2024 in Los Angeles, California to present our ViraxImmune range of T-cell assays & immune profiling solutions. Come meet our team at Booth 118 to discuss the latest product developments in our infectious disease pipeline. #vrax #viraxbiolabs #ViraxImmune #IDWeek #IDWeek2024 #infectiousdisease #immuneresponse #transplants

ICYMI, our team has been at IDWeek 2024! We'll be at Booth 118 until the end of the conference - we're always happy to connect with other infectious disease professionals & speak about our ViraxImmune range of T-cell assays and immune profiling solutions. #vrax #viraxbiolabs #viraximmune #IDWeek2024 #infectiousdiseases

IDWeek 2024 begins tomorrow! Please come visit us at Booth 118 - we're excited to be meeting with other infectious disease professionals & we're looking forward to presenting the products and insights from our ViraxImmune platform. #vrax #viraxbiolabs #ViraxImmune #IDWeek #IDWeek2024 #infectiousdiseases

We're pleased to announce that we will be at IDWeek 2024 in Los Angeles, California from October 16-19 to present our ViraxImmune range of T-cell assays & immune profiling solutions. Come meet our team at Booth 118 to discuss the latest product developments in our infectious disease pipeline. #vrax #viraxbiolabs #ViraxImmune #IDWeek #IDWeek2024 #infectiousdisease

We're pleased to announce that we will be at IDWeek 2024 in Los Angeles, California from October 16-19 to present our ViraxImmune range of T-cell assays & immune profiling solutions. Come meet our team at Booth 118 to discuss the latest product developments in our infectious disease pipeline. #vrax #viraxbiolabs #ViraxImmune #IDWeek #IDWeek2024 #infectiousdisease